Epilessia e anti-GAD nei pazienti con DMT1: Esiste un link?

Translated title of the contribution: Epilepsy and anti-GAD in T1DM: Looking for a link

M. M. Mancardi, A. Giannattasio, P. Striano, G. Prato, N. Minuto, M. G. Baglietto, R. Gaggero, E. Veneselli, G. D'Annunzio

Research output: Contribution to journalArticlepeer-review


Anti-GAD antibodies may decrease the conversion into GABA with outweighting of excitatory neurotransmitters. Anti-GAD are mainly implicated in the pathogenesis of type 1 diabetes, but have been recently described in association with focal epilepsy. We retrospectively investigated frequency and type of epilepsy among diabetic patient series (n = 286) followed at our Hospital, with the attempt to find a correlation with serum anti-GAD. Seven patients presented idiopathic/cryptogenic epilepsy: 4 of the generalized type, 2 focal and 1 with epileptic encephalopathy (4/7 were positive for anti-GAD).

Translated title of the contributionEpilepsy and anti-GAD in T1DM: Looking for a link
Original languageItalian
Pages (from-to)51-53
Number of pages3
JournalBollettino - Lega Italiana contro l'Epilessia
Issue number138
Publication statusPublished - 2008

ASJC Scopus subject areas

  • Clinical Neurology


Dive into the research topics of 'Epilepsy and anti-GAD in T1DM: Looking for a link'. Together they form a unique fingerprint.

Cite this